Black Triangle Scheme And Formal Inspections On the Cards In Australia
Executive Summary
New pharmacovigilance-enhancing proposals from Australia’s Therapeutic Goods Administration signal the agency’s intention to become more proactive when it comes to monitoring drug sponsors.
You may also be interested in...
No Delays Expected As Australian Bill On Faster Drug Approvals Goes To Parliament
The Australian parliament has held its first reading of a bill that will implement a number of new measures in the pharmaceutical area, including two new expedited drug approval pathways and a risk-based approach to variations.
Black triangle for monitored EU drugs to kick in on 1 September
As of 1 September, the product information for all new EU drugs that are subjected to additional monitoring under the pharmacovigilance legislation will have to bear an inverted black triangle1.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.